HDAC Inhibitors - Novel Therapies in Combination with Immune Checkpoint Inhibitors for Treatment of Advanced and Unresectable Melanoma - A Mini Review

John Ning, Farbod Shojaei, Mireille Gillings, Fairooz Kabbinavar and Lalitha Aiyer
Additional contact information
Lalitha Aiyer: Clinical Psychologist, Germans Trias i Pujol University Hospital, Spain

Biomedical Journal of Scientific & Technical Research, 2022, vol. 43, issue 2, 34470-34478

Abstract: Until recently there were few options for the treatment of metastatic melanoma with chemotherapy agents...

Keywords: Medical Microbiology; Physical Medicine and Rehabilitation; Preventive Medicine; Regenerative Medicine; Journals on Psychology; Immunological Diseases; Clinical Pathology; Infectious Diseases Addiction Science; Bio-psychological Medicine; Journals on Vaccination (search for similar items in EconPapers)
Date: 2022
References: Add references at CitEc
Citations:

Downloads: (external link)
https://biomedres.us/pdfs/BJSTR.MS.ID.006887.pdf (application/pdf)
https://biomedres.us/fulltexts/BJSTR.MS.ID.006887.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:abf:journl:v:43:y:2022:i:2:p:34470-34478

DOI: 10.26717/BJSTR.2022.43.006887

Access Statistics for this article

Biomedical Journal of Scientific & Technical Research is currently edited by Robert Thomas

More articles in Biomedical Journal of Scientific & Technical Research from Biomedical Research Network+, LLC
Bibliographic data for series maintained by Angela Roy ().